why choose us

First received: February 17, 2023

Clinical Trial: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults

Brief Summary: The purpose of this trial is to evaluate immunogenicity and safety of CVXGA administered as a single intranasal dose against SARS-CoV-2 S-protein in participants.The trial will enroll up to 400 healthy participants, age 18-80 years.

Read more